Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 5,417 | 9,664 | 13,709 | 16,522 | 10,305 |
| Gross Profit | 5,417 | 9,664 | 13,709 | 16,522 | 10,305 |
| Operating Expenses | 43,592 | 51,193 | 47,870 | 44,449 | 30,968 |
| Operating Income | -38,175 | -41,530 | -34,161 | -27,927 | -20,663 |
| Interest Expense | 0 | 210 | 478 | 674 | 387 |
| Other Income | 990 | 2,979 | 3,402 | 1,102 | 519 |
| Pre-tax Income | -37,186 | -38,761 | -31,237 | -27,499 | -20,530 |
| Net Income Continuous | -37,186 | -38,761 | -31,237 | -27,499 | -20,530 |
| Net Income | $-37,186 | $-38,761 | $-31,237 | $-27,499 | $-20,530 |
| EPS Basic Total Ops | -1,362.70 | -1,511.47 | -1,423.30 | -21,928.92 | -19,863.25 |
| EPS Basic Continuous Ops | -1,362.38 | -1,509.64 | -1,417.44 | -5,217.92 | -19,860.98 |
| EPS Diluted Total Ops | -1,362.70 | -1,511.47 | -1,423.30 | -21,928.92 | -19,863.25 |
| EPS Diluted Continuous Ops | -1,362.38 | -1,509.64 | -1,417.44 | -5,217.92 | -19,860.98 |
| EBITDA(a) | $-37,071 | $-39,801 | $-32,579 | $-26,067 | $-18,492 |